BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36961993)

  • 1. Heterogeneity in meta-analysis: a comprehensive overview.
    Stogiannis D; Siannis F; Androulakis E
    Int J Biostat; 2024 May; 20(1):169-199. PubMed ID: 36961993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis methods for genome-wide association studies and beyond.
    Evangelou E; Ioannidis JP
    Nat Rev Genet; 2013 Jun; 14(6):379-89. PubMed ID: 23657481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework.
    Murphy P; Glynn D; Dias S; Hodgson R; Claxton L; Beresford L; Cooper K; Tappenden P; Ennis K; Grosso A; Wright K; Cantrell A; Stevenson M; Palmer S
    Health Technol Assess; 2021 Dec; 25(76):1-228. PubMed ID: 34990339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statistical primer: methodology and reporting of meta-analyses.
    Buccheri S; Sodeck GH; Capodanno D
    Eur J Cardiothorac Surg; 2018 Apr; 53(4):708-713. PubMed ID: 29538746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive distributions for between-study heterogeneity and simple methods for their application in Bayesian meta-analysis.
    Turner RM; Jackson D; Wei Y; Thompson SG; Higgins JP
    Stat Med; 2015 Mar; 34(6):984-98. PubMed ID: 25475839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioural interventions for smoking cessation: an overview and network meta-analysis.
    Hartmann-Boyce J; Livingstone-Banks J; Ordóñez-Mena JM; Fanshawe TR; Lindson N; Freeman SC; Sutton AJ; Theodoulou A; Aveyard P
    Cochrane Database Syst Rev; 2021 Jan; 1():CD013229. PubMed ID: 33411338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics.
    Bowden J; Tierney JF; Copas AJ; Burdett S
    BMC Med Res Methodol; 2011 Apr; 11():41. PubMed ID: 21473747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical approaches for conducting network meta-analysis in drug development.
    Jones B; Roger J; Lane PW; Lawton A; Fletcher C; Cappelleri JC; Tate H; Moneuse P;
    Pharm Stat; 2011; 10(6):523-31. PubMed ID: 22213533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dealing with clinical heterogeneity in meta-analysis. Assumptions, methods, interpretation.
    Kriston L
    Int J Methods Psychiatr Res; 2013 Mar; 22(1):1-15. PubMed ID: 23494781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis: the fashion of summing-up evidence. Part I. Rationale and conduct.
    Gelber RD; Goldhirsch A
    Ann Oncol; 1991 Jul; 2(7):461-8. PubMed ID: 1911452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A methodological review of how heterogeneity has been examined in systematic reviews of diagnostic test accuracy.
    Dinnes J; Deeks J; Kirby J; Roderick P
    Health Technol Assess; 2005 Mar; 9(12):1-113, iii. PubMed ID: 15774235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to letter to the editor from Dr Rahman Shiri: The challenging topic of suicide across occupational groups.
    Niedhammer I; Milner A; Witt K; Klingelschmidt J; Khireddine-Medouni I; Alexopoulos EC; Toivanen S; Chastang JF; LaMontagne AD
    Scand J Work Environ Health; 2018 Jan; 44(1):108-110. PubMed ID: 29218357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dealing with missing standard deviation and mean values in meta-analysis of continuous outcomes: a systematic review.
    Weir CJ; Butcher I; Assi V; Lewis SC; Murray GD; Langhorne P; Brady MC
    BMC Med Res Methodol; 2018 Mar; 18(1):25. PubMed ID: 29514597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Microsoft-Excel-based tool for running and critically appraising network meta-analyses--an overview and application of NetMetaXL.
    Brown S; Hutton B; Clifford T; Coyle D; Grima D; Wells G; Cameron C
    Syst Rev; 2014 Sep; 3():110. PubMed ID: 25267416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The application of knowledge synthesis methods in agri-food public health: recent advancements, challenges and opportunities.
    Young I; Waddell L; Sanchez J; Wilhelm B; McEwen SA; Rajić A
    Prev Vet Med; 2014 Mar; 113(4):339-55. PubMed ID: 24485274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Bayesian meta-analytic approach for safety signal detection in randomized clinical trials.
    Odani M; Fukimbara S; Sato T
    Clin Trials; 2017 Apr; 14(2):192-200. PubMed ID: 28059578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The uptake of Bayesian methods in biomedical meta-analyses: A scoping review (2005-2016).
    Grant RL
    J Evid Based Med; 2019 Feb; 12(1):69-75. PubMed ID: 30511364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.